Works matching DE "MAJOR adverse cardiovascular events"

Results: 2766

Determinants of artificial intelligence electrocardiogram-derived age and its association with cardiovascular events and mortality: a systematic review and meta-analysis.

Published in:

NPJ Digital Medicine, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s41746-025-01727-7

By:

Mossavarali, Shervin;
Vaezi, Ali;
Gholami, Zahra;
Molaei, Alireza;
Yekaninejad, Mir Saeed;
Asselbergs, Folkert W.;
Shafiee, Akbar

Publication type:

Article

Safety and efficacy of filgotinib in Japanese patients with rheumatoid arthritis: Week 156 interim results in FINCH 4.

Published in:

Modern Rheumatology, 2025, v. 35, n. 3, p. 425, doi. 10.1093/mr/roae099

By:

Tanaka, Yoshiya;
Matsubara, Tsukasa;
Atsumi, Tatsuya;
Amano, Koichi;
Ishiguro, Naoki;
Hirata, Shintaro;
Yamaoka, Kunihiro;
Combe, Bernard G;
Nash, Peter;
Genovese, Mark;
Pechonkina, Alena;
Liu, Jie;
Kondo, Akira;
Fukada, Haruhiko;
De Leonardis, Francesco;
Takeuchi, Tsutomu

Publication type:

Article

Is Influenza Vaccination Our Best 'Shot' at Preventing MACE? Review of Current Evidence, Underlying Mechanisms, and Future Directions.

Published in:

Vaccines, 2025, v. 13, n. 5, p. 522, doi. 10.3390/vaccines13050522

By:

El Khoury, Alexia;
Abou Farah, Joy;
Saade, Elie

Publication type:

Article

Cardiac Repair and Clinical Outcomes of Stem Cell Therapy in Heart Failure: A Systematic Review and Meta-Analysis.

Published in:

Diseases, 2025, v. 13, n. 5, p. 136, doi. 10.3390/diseases13050136

By:

Muslem, Salman;
AlTurani, Mariam;
Maqsood, Muhammad Bilal;
Qaseer, Maryam Al

Publication type:

Article

The Risk of Adverse Cardiac Events after Pneumonia in Patients with Coronary Artery Disease.

Published in:

Annals of the American Thoracic Society, 2025, v. 22, n. 6, p. 855, doi. 10.1513/AnnalsATS.202407-714OC

By:

Bartlett, Benjamin;
Sanfilippo, Frank M.;
Lee, Silvia;
Ludewick, Herbert;
Waterer, Grant;
Rajwani, Adil;
Bharat, Chrianna;
Ihdayhid, Abdul Rahman;
Corrales-Medina, Vicente;
Dwivedi, Girish

Publication type:

Article

SGLT-2 Inhibitors and the Risk of Chronic Obstructive Pulmonary Disease Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease Patients.

Published in:

Annals of the American Thoracic Society, 2025, v. 22, n. 6, p. 846, doi. 10.1513/AnnalsATS.202407-703OC

By:

Yen, Fu-Shun;
Wei, James Cheng-Chung;
Huang, Yu-Han;
Hsu, Tzu-Ju;
Wang, Sing-Ting;
Hwu, Chii-Min;
Hsu, Chih-Cheng

Publication type:

Article

EBM BLS: Ticagrelor without aspirin one month after percutaneous coronary intervention reduces bleeding without worse cardiovascular outcomes.

Published in:

JGIM: Journal of General Internal Medicine, 2025, v. 40, n. 8, p. 1966, doi. 10.1007/s11606-024-09313-5

By:

Nolan, Eric;
Ammon, Jessica;
Cunningham, John M.

Publication type:

Article

Comparative evaluation of the ability to detect major cardiac events with the modified cocaine history, electrocardiogram, age, risk factors and troponin (HEART) score, HEART pathway and original HEART score in patients with cocaine-associated chest pain presenting at the emergency department

Published in:

Clinical Toxicology (15563650), 2025, v. 63, n. 5, p. 317, doi. 10.1080/15563650.2025.2472955

By:

Gresnigt, Femke;
van Essen, Jelle;
Hunault, Claudine;
Franssen, Eric;
de Lange, Dylan;
Riezebos, Robert

Publication type:

Article

The Naples prognostic score in TAVI patients: A promising tool requiring further validation. Authors' reply.

Published in:

Polish Heart Journal / Kardiologia Polska, 2025, v. 83, n. 5, p. 660, doi. 10.33963/v.phj.106386

By:

Gitmez, Mesut;
Güzel, Tuncay;
Kis, Mehmet;
Coskun, Ferhat;
İsik, Mehmet Ali;
Aktan, Adem;
Kilic, Raif;
Demir, Muhammed;
Ertas, Faruk

Publication type:

Article

The Naples Prognostic Score in TAVR patients: A promising tool requiring further validation.

Published in:

Polish Heart Journal / Kardiologia Polska, 2025, v. 83, n. 5, p. 658, doi. 10.33963/v.phj.106115

By:

Dziewierz, Artur;
Gąsecka, Aleksandra;
Kleczyński, Paweł

Publication type:

Article

Comment on: 'Effects of age, sex, daily dose, comorbidity and co‐medication on venlafaxine‐associated cardiovascular adverse events: A pharmacovigilance analysis of the FDA adverse event reporting system database'.

Published in:

British Journal of Clinical Pharmacology, 2025, v. 91, n. 6, p. 1873, doi. 10.1111/bcp.70089

By:

Masuda, Rikuto;
Noguchi, Yoshihiro;
Kobayashi, Ryo;
Yoshimura, Tomoaki

Publication type:

Article

Evaluating the impact of metabolic indicators and scores on cardiovascular events using machine learning.

Published in:

Diabetology & Metabolic Syndrome, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13098-025-01753-1

By:

Li, Guanmou;
Luo, Cheng;
Ge, Teng;
He, Kunyang;
Zhang, Miao;
Hu, Jinlin;
Zheng, Baoshi;
Zou, Rongjun;
Fan, Xiaoping

Publication type:

Article

Relationship Between Level of Trimethylamine Oxide and the Risk of Recurrent Cardiovascular Events in Patients with Acute Myocardial Infarction.

Published in:

Nutrients, 2025, v. 17, n. 10, p. 1664, doi. 10.3390/nu17101664

By:

Ji, Wenjun;
Zhang, Bin;
Liu, Jiahui;
Li, Kaiyin;
Jia, Jia;
Fan, Fangfang;
Jiang, Jie;
Wang, Xingang;
Zhang, Yan

Publication type:

Article

Impact of persistence to secondary preventive medication on prognosis for patients with myocardial infarction with and without obstructive coronary arteries.

Published in:

PLoS ONE, 2025, v. 20, n. 5, p. 1, doi. 10.1371/journal.pone.0324533

By:

Nordenskjöld, Anna M.;
Lindhagen, Lars;
Wettermark, Björn;
Lindahl, Bertil

Publication type:

Article

Automated abdominal aortic calcification and major adverse cardiovascular events in people undergoing osteoporosis screening: the Manitoba Bone Mineral Density Registry.

Published in:

Journal of Bone & Mineral Research, 2025, v. 40, n. 3, p. 323, doi. 10.1093/jbmr/zjae208

By:

Smith, Cassandra;
Sim, Marc;
Ilyas, Zaid;
Gilani, Syed Zulqarnain;
Suter, David;
Reid, Siobhan;
Monchka, Barret A;
Jozani, Mohammed Jafari;
Figtree, Gemma;
Schousboe, John T;
Lewis, Joshua R;
Leslie, William D

Publication type:

Article

SGLT2 Inhibitors in Cancer Patients: A Comprehensive Review of Clinical, Biochemical, and Therapeutic Implications in Cardio-Oncology.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 10, p. 4780, doi. 10.3390/ijms26104780

By:

Greco, Alessandra;
Canale, Maria Laura;
Quagliariello, Vincenzo;
Oliva, Stefano;
Tedeschi, Andrea;
Inno, Alessandro;
De Biasio, Marzia;
Bisceglia, Irma;
Tarantini, Luigi;
Maurea, Nicola;
Navazio, Alessandro;
Corda, Marco;
Iacovoni, Attilio;
Colivicchi, Furio;
Grimaldi, Massimo;
Oliva, Fabrizio

Publication type:

Article

Patterns of left ventricular trabeculation in hypertrophic cardiomyopathy.

Published in:

BMC Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12916-025-04142-7

By:

Zhang, Yu;
Zhou, Di;
Zhu, Yuming;
Huang, Qiya;
Wang, Jizheng;
Zhang, Channa;
Kang, Lianming;
Lu, Minjie;
Song, Lei

Publication type:

Article

Predicting the prognosis of diabetic patients undergoing percutaneous coronary intervention: the value of the Naples prognostic score in a real-world clinical study.

Published in:

BMC Cardiovascular Disorders, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12872-025-04849-8

By:

Zhou, Mengzhu;
Zhang, Xue;
Guo, Xiaohua;
Duan, Junying;
Zhang, Haifeng;
Liu, Xing;
Liu, Tong;
Chen, Kangyin;
Liu, Changle

Publication type:

Article

Microcirculatory dysfunction in patients with acute anterior myocardial infarction combined with new complete right bundle branch block.

Published in:

BMC Cardiovascular Disorders, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12872-025-04872-9

By:

Liu, Hong;
Yuan, Yu;
Dong, Yu;
Yang, Ying;
Yang, Xitong;
Sun, Biao;
Ma, Lilan;
Li, Tao;
Wu, Xin-Hua

Publication type:

Article

Sodium-glucose cotransporter 2 inhibitors in transthyretin amyloid cardiomyopathy: navigating potential benefits and uncertainties.

Published in:

Current Medical Research & Opinion, 2025, v. 41, n. 4, p. 657, doi. 10.1080/03007995.2025.2495167

By:

Karakasis, Paschalis

Publication type:

Article

GRACE, SYNTAX I, and SYNTAX II scores as predictors of one-year MACE in patients with myocardial infarction treated with percutaneous coronary intervention.

Published in:

Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2022, v. 79, n. 9, p. 868, doi. 10.2298/VSP200204055D

By:

Davidović, Aleksandar;
Cvijanović, Dane;
Davidović, Jelica;
Lazić, Snežana;
Lazić, Bratislav;
Čučić, Luka;
Milić, Marija;
Nikolić, Nataša Marković

Publication type:

Article

Development of one-year major adverse cardiac events risk index in patients with acute coronary syndrome and diabetes mellitus who underwent percutaneous coronary intervention.

Published in:

Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2020, v. 77, n. 11, p. 1192, doi. 10.2298/VSP181102026M

By:

Mirković, Marija;
Nedeljković, Milan;
Ružičić, Dušan;
Vuković, Mira

Publication type:

Article

Long-Term Prognostic Impact of Sex in Patients with Chronic Coronary Syndrome: A 17-Year Prospective Cohort Study.

Published in:

Journal of Women's Health (15409996), 2023, v. 32, n. 1, p. 63, doi. 10.1089/jwh.2022.0058

By:

Ruiz-Ortiz, Martín;
Sánchez-Fernández, Carlos;
Sánchez-Fernández, José J.;
Mateos-de-la-Haba, Leticia;
Barreiro-Mesa, Lucas;
Ogayar-Luque, Cristina;
Romo-Peñas, Elías;
Delgado-Ortega, Mónica;
Rodríguez-Almodóvar, Ana;
Esteban-Martínez, Fátima;
López-Aguilera, José;
Carrasco-Ávalos, Francisco;
Castillo-Domínguez, Juan C.;
Anguita-Sánchez, Manuel;
Pan, Manuel;
Mesa-Rubio, Dolores

Publication type:

Article

Sex differences identified in cardiovascular outcomes.

Published in:

Practitioner, 2022, v. 266, n. 1854, p. 7

By:

SAVILL, PETER

Publication type:

Article

Electrocardiographic Findings in Genotype-Positive and Non-sarcomeric Children with Definite Hypertrophic Cardiomyopathy and Subclinical Variant Carriers.

Published in:

Pediatric Cardiology, 2024, v. 45, n. 8, p. 1784, doi. 10.1007/s00246-023-03281-z

By:

Anvekar, Priyanka;
Stephens Jr., Paul;
Calderon-Anyosa, Renzo J. C.;
Kauffman, Hunter L.;
Burstein, Danielle S.;
Ritter, Alyssa L.;
Ahrens-Nicklas, Rebecca C.;
Vetter, Victoria L.;
Banerjee, Anirban

Publication type:

Article

Early and Long-Term Clinical Outcomes of Ductal Stenting Versus Surgical Aortopulmonary Shunt Among Young Infants with Duct-Dependent Pulmonary Circulation.

Published in:

Pediatric Cardiology, 2024, v. 45, n. 4, p. 787, doi. 10.1007/s00246-024-03415-x

By:

Singh, Gurbhej;
Gopalakrishnan, Arun;
Subramanian, Venkateshwaran;
Sasikumar, Deepa;
Sasidharan, Bijulal;
Dharan, Baiju S.;
Srinivasa Prasad, B. V.;
Menon, Sabarinath;
Valaparambil, Ajitkumar;
Krishnamoorthy, Kavassery Mahadevan;
Sivasubramonian, Sivasankaran;
Tharakan, Jaganmohan

Publication type:

Article

Deep learning–based prediction model of occurrences of major adverse cardiac events during 1-year follow-up after hospital discharge in patients with AMI using knowledge mining.

Published in:

Personal & Ubiquitous Computing, 2022, v. 26, n. 2, p. 259, doi. 10.1007/s00779-019-01248-7

By:

Kim, Young Joong;
Saqlian, Muhammad;
Lee, Jong Yun

Publication type:

Article

Revisiting the safety of romosozumab in Japan: the need for clear contraindications for patients with cardiovascular risk.

Published in:

2025

By:

Kawaguchi, Hiroshi

Publication type:

Letter to the Editor

Comparative effectiveness and cardiovascular safety of romosozumab versus teriparatide in patients with osteoporosis: a population-based cohort study.

Published in:

Osteoporosis International, 2024, v. 35, n. 12, p. 2165, doi. 10.1007/s00198-024-07255-6

By:

Masuda, Soichiro;
Fukasawa, Toshiki;
Matsuda, Shuichi;
Yoshida, Satomi;
Kawakami, Koji

Publication type:

Article

Denosumab vs. bisphosphonates in primary osteoporosis: a meta-analysis of comparative safety in randomized controlled trials.

Published in:

Osteoporosis International, 2024, v. 35, n. 8, p. 1377, doi. 10.1007/s00198-024-07118-0

By:

Kobayashi, Takaomi;
Morimoto, Tadatsugu;
Ito, Koji;
Mawatari, Masaaki;
Shimazaki, Takafumi

Publication type:

Article

Comment on: Abdalbary et al. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study. Osteoporos Int. 2023 Apr;34(4):763–774.

Published in:

Osteoporosis International, 2023, v. 34, n. 10, p. 1815, doi. 10.1007/s00198-023-06873-w

By:

Martins, Maria João

Publication type:

Article

Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study.

Published in:

Osteoporosis International, 2023, v. 34, n. 4, p. 763, doi. 10.1007/s00198-023-06686-x

By:

Abdalbary, M.;
Chishti, E.;
Shakhashiro, M.;
Mohamed, R.;
Parikh, T.;
Nassar, M.K.;
Sayed-Ahmed, N.;
Faugere, M.-C.;
Sawaya, B.P.;
El-Husseini, A.

Publication type:

Article

Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claims database study.

Published in:

Osteoporosis International, 2022, v. 33, n. 8, p. 1703, doi. 10.1007/s00198-022-06413-y

By:

Cosman, F.;
Cooper, C.;
Wang, Y.;
Mitlak, B.;
Varughese, S.;
Williams, S. A.

Publication type:

Article

Effect of metoprolol exposure following myocardial infarction on future cardiovascular events: a Mendelian randomization study.

Published in:

European Journal of Clinical Pharmacology, 2025, v. 81, n. 4, p. 551, doi. 10.1007/s00228-025-03806-w

By:

Bruun, Lina Dorthea;
Andersen, Geir Øystein;
Kringen, Marianne Kristiansen;
Myhre, Peder Langeland;
Halvorsen, Sigrun;
Hansen, Charlotte Holst;
Molden, Espen;
Øie, Erik

Publication type:

Article

Efficacy and safety of ticagrelor monotherapy following a brief DAPT vs. prolonged 12-month DAPT in ACS patients post-PCI: a meta-analysis of RCTs.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 12, p. 1871, doi. 10.1007/s00228-024-03747-w

By:

Qamar, Usama;
Naeem, Farhan;
Maqsood, Muhammad Talha;
Khan, Maleeka Zamurad;
Imtiaz, Zeeshan;
Saeed, Fatima;
Gupta, Neelesh;
Brohi, Fnu Zafarullah;
Mkpozi, Celestine;
Sattar, Yasar

Publication type:

Article

Comparison of ticagrelor and clopidogrel in anemic patients with acute coronary syndrome: efficacy and safety outcomes over one year.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 5, p. 759, doi. 10.1007/s00228-024-03653-1

By:

Onuk, Tolga;
Polat, Fuat;
Yaylak, Barış;
Akyüz, Şükrü;
Kolak, Zeynep;
Durak, Furkan

Publication type:

Article

Efficacy and safety of bempedoic acid lipid-lowering therapy: a systematic review and meta-analysis of randomized controlled trials.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 11, p. 1453, doi. 10.1007/s00228-023-03555-8

By:

Venkatraman, Shravan;
Das, Saibal;
Eerike, Madhavi;
Cherian, Jerin Jose;
Bagepally, Bhavani Shankara

Publication type:

Article

The contribution of genotype-guided selection of P2Y<sub>12</sub> inhibitor on prognosis in ACS /CCS patients undergoing percutaneous coronary intervention: a retrospective cohort study.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1249, doi. 10.1007/s00228-023-03519-y

By:

Wu, Yan;
Yu, Dongbiao;
Zhang, Lei;
Wu, Yuting;
Shu, Bing;
Ma, Likun;
Shi, Tianlu

Publication type:

Article

Comparison of ticagrelor and clopidogrel on platelet function and prognosis in unstable angina.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 12, p. 1949, doi. 10.1007/s00228-022-03401-3

By:

Li, Chun;
Liu, Ming;
Chen, Weixiang;
Jiang, Tingbo;
Ling, Lin

Publication type:

Article

Evaluating the safety and efficacy of daprodustat for anemia of chronic kidney disease: a meta-analysis of randomized clinical trials.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 12, p. 1867, doi. 10.1007/s00228-022-03395-y

By:

Fatima, Kaneez;
Ahmed, Warda;
Fatimi, Asad Saulat;
Mahmud, Omar;
Mahar, Muhammad Umar;
Ali, Ayesha;
Aamir, Syed Roohan;
Nasim, Muhammad Taha;
Islam, Muhammad Bilal;
Maniya, Muhammad Talha;
Azim, Dua;
Marsia, Shayan;
Almas, Talal

Publication type:

Article

Exploring heterogeneities of cardiovascular efficacy and effectiveness of SGLT2 inhibitors in patients with type 2 diabetes: an umbrella review of evidence from randomized clinical trials versus real-world observational studies.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 8, p. 1205, doi. 10.1007/s00228-022-03327-w

By:

Seo, Bojung;
Su, Jialin;
Song, Yiqing

Publication type:

Article

Semaglutide Linked to Reduced Risk for MACE Months Before Weight Loss Begins: Post Hoc Analysis.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Halsey, Grace

Publication type:

Article

Atopic Dermatitis Treatment Caution: Long-Term Oral Corticosteroid Use Ups Cardiovascular and Thrombotic Risks.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Halsey, Grace

Publication type:

Article

ACC 2025: Cardiovascular Benefits of Semaglutide 2.4 mg Highlighted in Real-World Study.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Jennings, Sydney

Publication type:

Article

Oral Semaglutide Lowers Risk of MACE 14% in High-Risk Adults: Final Phase 3 SOUL Trial Readout.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Halsey, Grace

Publication type:

Article

Initial Treatment with Dual Statin + Ezetimibe Cuts All-Cause Mortality by 50%: New Meta-Analysis.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Halsey, Grace

Publication type:

Article

Nonsteroidal Topical Treatments for Eczema: A Product Snapshot with Mona Shahriari, MD: They are a Janus kinase (JAK)1/JAK2 inhibitor, a phosphodiesterase-4 inhibitor, and an investigational aryl hydrocarbon receptor agonist. Learn more about each.

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

Oral Semaglutide Linked to Lower Risk of MACE: Daily Dose.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

COVID-19 Raises Risk of MACE up to 3 Years Later: Daily Dose.

Published in:

Patient Care (Online), 2024, p. 1

By:

Sydney, Sydney

Publication type:

Article

Oral Semaglutide Shows 14% Reduction in MACE in Adults with T2D, ASCVD, and/or CKD: Topline Results from Phase 3 SOUL Trial.

Published in:

Patient Care (Online), 2024, p. 3

By:

Halsey, Grace

Publication type:

Article